The lipid kinase PI3KC2a is a potential pharmacological target for the treatment of thrombosis and, possibly, cancer. Researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) have now identified a potent inhibitor of its activity that serves as a lead for further drug development.
Click here for original story, Inhibitor of lipid kinase PI3KC2a identified as potential new treatment of thrombosis
Source: Phys.org